Support services (biologist 21/22/23) for the laboratory of genome integrity, center for cancer research, national cancer institute ncioa-TSB-SSS-071
Ended Awarded Last action
- Contract number
- 75N91021F00017
- Awardee
-
Astrix Technology LLC UEI NRVNN8E6NCK4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $427,421
Award facts
- Contract value 100% obligated
- $427,421.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Red Bank, NJ, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$42,008 | |
| Exercise an Option | $160,232 | |
| Exercise an Option | $156,450 | |
| Original award | $152,748 |
About this award
The National Cancer Institute issued a BPA call to Astrix Technology LLC under the GSA Multiple Award Schedule (MAS) on November 16, 2020, with a ceiling value of $427,421.36. The call supports the Laboratory of Genome Integrity, Center for Cancer Research, and provides biologist services through the ultimate completion date of November 15, 2023. Work is performed in Red Bank, New Jersey.
Service Contract Inventory reporting shows the call invoiced $427 thousand across FY2021–FY2024, declining sharply in FY2024 as the ultimate completion date approached. Government-paid hourly rates rose modestly from $74.62/hr in FY2021 to $78.40/hr in FY2024. Peak utilization occurred in FY2023 at 0.9 FTEs and 1,912 contractor hours; FY2024 activity dropped to 0.1 FTEs and 288 hours as the call wound down. Astrix self-performed all reported hours with no subcontractor involvement. The call was issued to de-obligate expiring FY2021 funding in accordance with 31 U.S.C. Section 1552(a).
Quick answers
Who was awarded contract 75N91021F00017?
75N91021F00017 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on November 16, 2020.
How much is contract 75N91021F00017 worth?
The government has obligated $427,421 on 75N91021F00017.
Is contract 75N91021F00017 an order under another contract?
Yes. 75N91021F00017 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75N91021F00017 competed?
The extent of competition for 75N91021F00017 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award